Orally Administered Corticosteroid Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 61/247,642, filed Oct 1, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,387,167 | Orally Administered Corticosteroid Compositions In force · High confidence UsedRemaining | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 9,486,407 | Orally Administered Corticosteroid Compositions In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 9,849,084 | Orally Administered Corticosteroid Compositions In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 10,632,069 | Orally Administered Corticosteroid Compositions In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 11,246,828 | Orally Administered Corticosteroid Compositions In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 11,266,598 | Orally Administered Corticosteroid Compositions In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 12,290,598 | Orally Administered Corticosteroid Compositions In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 8,771,729 | Orally Administered Corticosteroid Compositions In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| Application 19/170,231 | Orally Administered Corticosteroid Compositions Pending Not granted | Ellodi Pharmaceuticals, L.P. | Pending | Not granted | ||
| Application 19/403,672 | Orally Administered Corticosteroid Compositions Abandoned Abandoned Oct 31, 2026 | Ellodi Pharmaceuticals, L.P. | Abandoned | Abandoned Oct 31, 2026 |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by Ellodi Pharmaceuticals, L.P..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.